Healthcare -
Biotechnology - NASDAQ - US
$ 681.58
-1.68 %
$ 73.7 B
Market Cap
16.85
P/E
REGN - CHANGE IN WORKING CAPITAL
Change in Working Capital REGN - Regeneron Pharmaceuticals, Inc.
-94.1 M
LAST VALUE
77.84%
2 YEAR CAGR
33.00%
5 YEAR CAGR
6.82%
10 YEAR CAGR